268 related articles for article (PubMed ID: 28109025)
1. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
Trehanpati N; Vyas AK
Scand J Immunol; 2017 Mar; 85(3):175-181. PubMed ID: 28109025
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.
Sherman AC; Trehanpati N; Daucher M; Davey RT; Masur H; Sarin SK; Kottilil S; Kohli A
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):665-72. PubMed ID: 23259453
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 modulates the balance between viral specific CD4
Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.
TrehanPati N; Kotillil S; Hissar SS; Shrivastava S; Khanam A; Sukriti S; Mishra SK; Sarin SK
J Clin Immunol; 2011 Jun; 31(3):509-20. PubMed ID: 21305387
[TBL] [Abstract][Full Text] [Related]
7. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
[TBL] [Abstract][Full Text] [Related]
8. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
Zhou Y; Zhang H; Li Y
Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
[TBL] [Abstract][Full Text] [Related]
9. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Cho HJ; Cheong JY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
[TBL] [Abstract][Full Text] [Related]
10. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of Regulatory T Cells and Secreted Immunomodulatory Cytokine IL-10 Levels in Patients with Hepatitis B].
Tuyji Tok Y; Şener AG; Aksoy Gökmen A; Demirdal T; Kaya S
Mikrobiyol Bul; 2020 Apr; 54(2):266-278. PubMed ID: 32723282
[TBL] [Abstract][Full Text] [Related]
14. CXCR5
Jin Y; Lang C; Tang J; Geng J; Song HK; Sun Z; Wang J
Int Immunopharmacol; 2017 Dec; 53():42-48. PubMed ID: 29032029
[TBL] [Abstract][Full Text] [Related]
15. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
Front Immunol; 2015; 6():49. PubMed ID: 25767469
[TBL] [Abstract][Full Text] [Related]
17. The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells.
Broholm M; Mathiasen AS; Apol ÁD; Weis N
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793588
[TBL] [Abstract][Full Text] [Related]
18. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z
Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340
[TBL] [Abstract][Full Text] [Related]
19. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
20. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.
Kondo Y; Shimosegawa T
Int J Mol Sci; 2015 Feb; 16(2):3307-22. PubMed ID: 25654227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
